- Home
- ATYR vs BWFG Comparison
ATYR vs BWFG Comparison
Compare ATYR & BWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- BWFG
- Stock Information
- Founded
- ATYR 2005
- BWFG 2002
- Country
- ATYR United States
- BWFG United States
- Employees
- ATYR N/A
- BWFG N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- BWFG Major Banks
- Sector
- ATYR Health Care
- BWFG Finance
- Exchange
- ATYR Nasdaq
- BWFG Nasdaq
- Market Cap
- ATYR 228.1M
- BWFG 256.5M
- IPO Year
- ATYR 2015
- BWFG N/A
- Fundamental
- Price
- ATYR $3.63
- BWFG $29.83
- Analyst Decision
- ATYR Strong Buy
- BWFG Buy
- Analyst Count
- ATYR 5
- BWFG 1
- Target Price
- ATYR $19.25
- BWFG $40.00
- AVG Volume (30 Days)
- ATYR 960.8K
- BWFG 15.3K
- Earning Date
- ATYR 03-13-2025
- BWFG 01-22-2025
- Dividend Yield
- ATYR N/A
- BWFG 2.64%
- EPS Growth
- ATYR N/A
- BWFG N/A
- EPS
- ATYR N/A
- BWFG 1.94
- Revenue
- ATYR $235,000.00
- BWFG $72,009,000.00
- Revenue This Year
- ATYR N/A
- BWFG N/A
- Revenue Next Year
- ATYR $1,080.92
- BWFG $9.07
- P/E Ratio
- ATYR N/A
- BWFG $15.59
- Revenue Growth
- ATYR N/A
- BWFG N/A
- 52 Week Low
- ATYR $1.42
- BWFG $22.47
- 52 Week High
- ATYR $4.23
- BWFG $35.25
- Technical
- Relative Strength Index (RSI)
- ATYR 53.70
- BWFG 46.11
- Support Level
- ATYR $3.17
- BWFG $29.35
- Resistance Level
- ATYR $3.83
- BWFG $30.89
- Average True Range (ATR)
- ATYR 0.25
- BWFG 0.91
- MACD
- ATYR -0.02
- BWFG 0.06
- Stochastic Oscillator
- ATYR 43.60
- BWFG 54.07
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses, and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.